MX9803694A - Derivados de 3-desoxi-3-desclandinosa de eritromicinas a y b. - Google Patents

Derivados de 3-desoxi-3-desclandinosa de eritromicinas a y b.

Info

Publication number
MX9803694A
MX9803694A MX9803694A MX9803694A MX9803694A MX 9803694 A MX9803694 A MX 9803694A MX 9803694 A MX9803694 A MX 9803694A MX 9803694 A MX9803694 A MX 9803694A MX 9803694 A MX9803694 A MX 9803694A
Authority
MX
Mexico
Prior art keywords
descladinose
erythromycins
deoxy
derivatives
pharmaceutical compositions
Prior art date
Application number
MX9803694A
Other languages
English (en)
Inventor
Yat Sun Or
Daniel T Chu
Richard L Elliott
Daisy Pireh
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/729,269 external-priority patent/US5747466A/en
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of MX9803694A publication Critical patent/MX9803694A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Un compuesto seleccionado a partir de los grupos (I), (II), y (III), en donde A, B, V, W, X, y R8 se definen específicamente; composiciones farmacéuticas del mismo; un método para tratar o prevenir infecciones bacterianas mediante la administracion de composiciones farmacéuticas terapéuticamente efectivas del mismo; y un proceso para su preparacion.
MX9803694A 1995-11-08 1998-05-08 Derivados de 3-desoxi-3-desclandinosa de eritromicinas a y b. MX9803694A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US634295P 1995-11-08 1995-11-08
US08/729,269 US5747466A (en) 1995-11-08 1996-10-10 3-deoxy-3-descladinose derivatives of erythromycins A and B

Publications (1)

Publication Number Publication Date
MX9803694A true MX9803694A (es) 1998-09-30

Family

ID=26675509

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9803694A MX9803694A (es) 1995-11-08 1998-05-08 Derivados de 3-desoxi-3-desclandinosa de eritromicinas a y b.

Country Status (13)

Country Link
EP (1) EP0874863B1 (es)
JP (1) JP2000501077A (es)
KR (1) KR19990067333A (es)
AT (1) ATE231878T1 (es)
AU (1) AU714176B2 (es)
CA (1) CA2235681A1 (es)
DE (1) DE69626040T2 (es)
DK (1) DK0874863T3 (es)
ES (1) ES2191778T3 (es)
IL (1) IL123386A0 (es)
MX (1) MX9803694A (es)
PT (1) PT874863E (es)
WO (1) WO1997017357A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2757518B1 (fr) * 1996-12-23 1999-06-11 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
ITMI20021726A1 (it) * 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
US5523399A (en) * 1991-12-27 1996-06-04 Taisho Pharmaceutical Co., Ltd. 5-O-desosaminylerythronolide derivatives

Also Published As

Publication number Publication date
CA2235681A1 (en) 1997-05-15
IL123386A0 (en) 1998-09-24
DE69626040T2 (de) 2004-01-22
AU1074497A (en) 1997-05-29
AU714176B2 (en) 1999-12-23
EP0874863A1 (en) 1998-11-04
WO1997017357A1 (en) 1997-05-15
ATE231878T1 (de) 2003-02-15
PT874863E (pt) 2003-06-30
JP2000501077A (ja) 2000-02-02
DK0874863T3 (da) 2003-05-26
EP0874863B1 (en) 2003-01-29
ES2191778T3 (es) 2003-09-16
KR19990067333A (ko) 1999-08-16
DE69626040D1 (de) 2003-03-06

Similar Documents

Publication Publication Date Title
AU5669398A (en) Novel cyclosporin derivatives, method of preparation and pharmaceutical compositions containing them
CA2253338A1 (en) 6-o-substituted erythromycins and method for making them
DE69726577D1 (en) Kristallin form i von clarithromycin
EP0828481A4 (en) ORAL DELIVERY COMPOSITION FOR INTESTINAL RELEASE AND METHOD OF USE
UA43323C2 (uk) Антибіотичні похідні глікопептидів, спосіб отримання та фармацевтична композиція
HUT62467A (en) Process for producing locally applicable pharmaceutical compositions comprising allylamine derivative, against fungus infection of nails
HUT62466A (en) Process for producing locally applicable pharmaceutical compositions comprising allylamine derivatives, against fungus infection
YU11699A (sh) 6-supstituisani ketolidi koji imaju antibakterijsko dejstvo, postupci za njihovo dobijanje i njihovi farmaceutski preparati
BG102312A (en) New derivatives of 5-oxy-deoaminyl 6-oxy-methyl erythronolide a, method for their preparation and application for the preparation of biologically active products
FI951468A (fi) Lipopeptidijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö
DE69631609D1 (en) Tricyclische erythromycinderivate
IL117091A0 (en) Methylphenyloxazolidinone derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
AP2001002131A0 (en) Novel macrolide antibiotics.
AU5254696A (en) Reduced toxicity compositions and methods for treating hiv infections
IL126625A0 (en) 6-o-substituted erythromycin compounds and method for making same
AU1306795A (en) Anticonvulsant pseudofructopyranose sulfamates
MX9708611A (es) Compuestos de dialquiltiacumicina.
MD1788G2 (ro) Derivaţi de 9-O-oximă ai Eritromicinei A, compoziţie farmaceutică pe baza lor şi metodă de tratament al bolilor infecţioase
CA2218643A1 (en) Oral pharmaceutical composition of piperidinoalkanol compounds in solution form
MX9803694A (es) Derivados de 3-desoxi-3-desclandinosa de eritromicinas a y b.
UA48982C2 (uk) Поліморфи проліків тровафлоксацину, спосіб їх отримання, спосіб лікування бактеріальної інфекції і фармацевтична композиція
IL114646A0 (en) Method of inhibiting leukotriene biosynthesis
CA2386527A1 (en) Crystal form i of clarithromycin
AU5508399A (en) Erythromycin derivative with antibiotic activity